Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999

被引:261
作者
Critchley, J
Liu, J
Zhao, D
Wei, W
Capewell, S
机构
[1] Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Res Grp, Liverpool L3 5QA, Merseyside, England
[2] Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing, Peoples R China
[3] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England
关键词
coronary disease; mortality; risk factors; prevention;
D O I
10.1161/01.CIR.0000140668.91896.AE
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Coronary heart disease (CHD) mortality is rising in many developing countries. We examined how much of the increase in CHD mortality in Beijing, China, between 1984 and 1999 could be attributed to changes in major cardiovascular risk factors and assessed the impact of medical and surgical treatments. Methods and Results-A validated, cell-based mortality model synthesized data on (1) patient numbers, (2) uptake of specific medical and surgical treatments, (3) treatment effectiveness, and (4) population trends in major cardiovascular risk factors ( smoking, total cholesterol, blood pressure, obesity, and diabetes). Main data sources were the WHO MONICA and Sino-MONICA studies, the Chinese Multi-provincial Cohort Study, routine hospital statistics, and published meta-analyses. Age-adjusted CHD mortality rates increased by approximate to50% in men and 27% in women (1608 more deaths in 1999 than expected by application of 1984 rates). Most of this increase (approximate to77%, or 1397 additional deaths) was attributable to substantial rises in total cholesterol levels (more than 1 mmol/L), plus increases in diabetes and obesity. Blood pressure decreased slightly, whereas smoking prevalence increased in men but decreased substantially in women. In 1999, medical and surgical treatments in patients together prevented or postponed approximate to642 deaths, mainly from initial treatments for acute myocardial infarction (approximate to41%), hypertension (24%), angina (15%), secondary prevention (11%), and heart failure (10%). Multiway sensitivity analyses did not greatly influence the results. Conclusions-Much of the dramatic CHD mortality increases in Beijing can be explained by rises in total cholesterol, reflecting an increasingly "Western" diet. Without cardiological treatments, increases would have been even greater.
引用
收藏
页码:1236 / 1244
页数:9
相关论文
共 62 条
[1]   MEDICAL-MANAGEMENT AND THE DECLINE IN MORTALITY FROM CORONARY HEART-DISEASE [J].
BEAGLEHOLE, R .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6512) :33-35
[2]   Global cardiovascular disease prevention: time to get serious [J].
Beaglehole, R .
LANCET, 2001, 358 (9282) :661-663
[3]  
BEIFAN Z, 2002, 2 5 CONT INT S CARD
[4]   Economics notes - Handling uncertainty in economic evaluation [J].
Briggs, A .
BRITISH MEDICAL JOURNAL, 1999, 319 (7202) :120-120
[5]   Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 [J].
Capewell, S ;
Morrison, CE ;
McMurray, JJ .
HEART, 1999, 81 (04) :380-386
[6]   Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993 [J].
Capewell, S ;
Beaglehole, R ;
Seddon, M ;
McMurray, J .
CIRCULATION, 2000, 102 (13) :1511-1516
[7]   SERUM-CHOLESTEROL CONCENTRATION AND CORONARY HEART-DISEASE IN POPULATION WITH LOW CHOLESTEROL CONCENTRATIONS [J].
CHEN, ZM ;
PETO, R ;
COLLINS, R ;
MACMAHON, S ;
LU, JR ;
LI, WX .
BRITISH MEDICAL JOURNAL, 1991, 303 (6797) :276-282
[8]   Early health effects of the emerging tobacco epidemic in China - A 16-year prospective study [J].
Chen, ZM ;
Xu, Z ;
Collins, R ;
Li, WX ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (18) :1500-1504
[9]  
*COORD GROUP PATH, 1983, CHIN J PATHOL, V12, P81
[10]   Life-years gained from coronary heart disease mortality reduction in Scotland - Prevention or treatment? [J].
Critchley, JA ;
Capewell, S ;
Unal, B .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (06) :583-590